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The Chicken Microbiome and Health
Detailed studies of the chickenmicrobiome have emerged in recent years, largely due to the impact of
next-generation sequencing (NGS). We increasingly understand how the microbiome is important
in health, in development of the gut and the immune system, and in maintenance of homeostasis.
Manipulation of the microbiota directly through probiotics or antimicrobials or indirectly through
feed and feed additives has long been used by the poultry industry to increase growth rates and
feed conversion, to improve gut health, and to reduce the burden of pathogens and, in particular,
to reduce the load of foodborne zoonotic pathogens such as Salmonella and Campylobacter. We
can now begin to mechanistically determine how these treatments affect the microbiota and the
wider host, and this understanding will allow us to use more targeted approaches in the future. In
terms of food security, increasing yield is clearly a good thing. However, it is far from clear what
represents a “healthy” microbiome, and the lines between what is a “harmless” commensal and what
is a pathogen are often blurred. As such an understanding of themicrobial ecology of the gut and how
this is affected by manipulation of the microbiome or indeed treatment of “pathogens” is essential
in ensuring that treatments intended to improve health and productivity do not in fact cause more
problems.
Is it a Pathogen or a Commensal?
The chicken microbiome consists of around 1,000 bacterial species, though the composition varies
over time, between breeds and lines of birds, between flocks, individuals, and at different sites within
the gut (1–5). Proteobacteria make up a relatively small amount of species in the microbiome, but
among these species are a number that may cause disease in the chicken, notably Escherichia coli
and Clostridium perfringens, and as such are often considered pathogens (4–6). In contrast, the
foodborne zoonotic pathogen Campylobacter jejuni is also found frequently as a component of
the cecal microbiome but is often considered to be a “harmless commensal.” However, in reality,
these species can have the properties of either pathogen or commensal depending on the bacterial
pathotype, host immune status, diet, and coinfection.
Of these three exemplars, E. coli has perhaps the least direct impact on gut health. However,
extraintestinal infections are a considerable health problem in both broiler and layer chicken
production. Isolates associated with disease are termed avian pathogenic E. coli or APEC. Much
effort has been directed at understanding the virulence factors and pathogenesis of APEC, and there
are clearly a number of pathotypes that can cause disease (7, 8). However, wider analysis of isolates
associated with systemic infection or colibacillosis of broiler chickens and those associated with a
healthy gut show that disease may be caused by isolates that harbor few, if any, APEC-associated
virulence factors while apparently “commensal” isolates carry numerous virulence factors (9). The
implication is that inmany clinical cases of colibacillosis, commensal bacteria act as an opportunistic
pathogen due to host factors, environmental stress, poor management, or as a secondary infection.
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As such infections are rarely investigated in detail such as geno-
typing of isolates; the more generic term of APEC has become
associated with all E. coli isolated from diseased chickens rather
than those E. coli isolates that are primary pathogens per se.
Campylobacter jejuni is the most common cause of foodborne
human gastrointestinal infection worldwide. Chicken is the main
reservoir of infection with around 70% of UK retail chicken
contaminated in recent surveys (10, 11). C. jejuni colonizes the
lower gastrointestinal tract of the chicken to a high level and has
been considered to be a commensal due to the absence of clinical
disease in experimental infection studies (12). However, in recent
years, we have begun to reassess this paradigm. Experimental
infection of broiler breeds with C. jejuni leads to an inflammatory
response and changes to gut structure (13–16). Generally, it would
appear that this inflammation is regulated by IL-10-producing
cells, but in some broiler breeds, regulation appears to be dys-
functional and infection may lead to prolonged inflammation,
damage, and diarrhea. Does this mean that C. jejuni is truly a
pathogen of the chicken or more a reflection of dysregulation
of mucosal immune regulation? Indeed, poor gut health is often
considered as a problem for broiler chickens. Wet litter, due to
loose feces mixed with the bedding substrate, and dysbacteriosis
are frequent problems in broiler production that affect produc-
tivity and animal welfare both directly and through resulting
problems such as pododermatitis and hock burn (17–19).Modern
broiler chickens have been successfully bred to efficiently convert
grain into protein and grow rapidly, reaching slaughter weight at
6–7weeks of age and we increasingly understand the genetic basis
for this (20, 21). This, however, may have consequences; well-
documented musculoskeletal problems are being addressed, but
problems with gut health may be less obvious and harder to deal
with.Onemay pose the question towhat extent are these problems
related to the composition of the microbiota and development
of a healthy gut or more a consequence of a defect in their gut
physiology or immune function? Additionally, to what extent
could inappropriate or poorly regulated responses to the “normal”
microbiota be contributing to poor gut health? The example of
C. jejuni illustrates how the balance in maintaining a healthy gut
is likely to be influenced by a large number of both host and
microbial factors.
Clostridia are a major component of the proteobacteria in the
chicken microbiome (5). Of these species, C. perfringens is the
most important in poultry health. Variants of C. perfringens are
associated with the gut of many species, and it can be generally
considered as a commensal. Yet, it may produce toxins associated
with disease including human food poisoning or in necrotic infec-
tions of the gut or deep tissue. In the chicken, the C. perfringens
toxin group A has become most associated with necrotic enteritis
(NE), these isolates producing alpha and particularly netB toxins
(22). Despite C. perfringens producing these toxins being closely
associated with NE, it had proved very difficult to fulfill Koch’s
postulates as such isolates are frequently found in healthy birds
and reliable experimental infection models for NE based on C.
perfringens infection alone have proved hard to develop. This is
largely due to most clinical disease being multifactorial involving
predisposing factors such as coinfection particularly with species
of the apicomplexan protozoan parasite Eimeria or due to dietary
factors such as diets high in non-starch polysaccharides (NSPs;
wheat, rye, and barley) or animal proteins that provide favorable
conditions for the growth of C. perfringens A and stress on birds
in production (23). Again it is difficult to define C. perfringens as
a true gut pathogen, but more of an opportunist that frequently
makes up part of the microbiome.
Manipulation of the Microbiome: Past and
Future Implications for Gut Health
Historically, currently and likely into the future, the chicken
microbiome has been manipulated perhaps more than any other
vertebrate species through the use of growth-promoting antimi-
crobials, prebiotic and probiotic treatments, and dietary addi-
tives (24–27). Feed additives such as enzymes have been used
to increase productivity. For example, the use of phytases to
allow the breakdown of plant phytates to be utilized in diet (28).
Other additives such as plantain NSPs have been proposed to
reduce the burden of infections such as Salmonella (29). The
use of growth-promoting antimicrobials has been banned in the
European Union since 2006 and their use in the USA is under
increasing pressure due to their role in development of antimicro-
bial resistance. Not unexpectedly, the use of antimicrobial growth
promoters affects the composition of the microbiota (30, 31), and
equally the withdrawal of both growth-promoting and anticoc-
cidial drugs will lead to change in the microbiota composition
in commercial flocks. Interestingly, a recent study on drug-free
broiler production systems in Canada showed an increase in C.
perfringens (32). Anecdotally, the increased prevalence of both
NE and colibacillosis in Europe has been blamed, at least in part,
on the withdrawal of growth promoters. While the overriding
problems associated with the emergence of antimicrobial resis-
tance rightly mean that growth-promoting antibiotics have been
or are being withdrawn, it clearly illustrates how themanipulation
of microbiota can have positive effects on health of the chicken.
Equally, we need to be aware that changing the microbiota or
modulating host responses that are affected by or effect changes
upon the microbiome may have undesirable effects. In the case
of growth promoters, this was their role in the development of
resistant bacteria and potential drug residues in the food chain.
As such a better understanding of microbial ecology and how
interventions impact on the microbiota and the host is needed
before we adopt such changes wholesale. Manipulation of the
microbiome may be used to improve productivity, although the
consequences of removing “detrimental” or enriching “beneficial”
taxa are likely to go beyond improving feed conversion. A per-
turbed microbiome may reveal commensals as having pathogenic
potential and lead to problems in development of the gut and
immune system and poor gut homeostasis. Manipulation of the
gut, the microbiome, and the immune response has all been
proposed in reducing the burden of carriage of foodborne bacte-
rial pathogens. Our work on feed supplementation with plantain
NSP showed successful inhibition of Salmonella invasion (29), but
rather unexpectedly lead to increased colonization of the intesti-
nal tract with Salmonella gallinarum. S. gallinarum has evolved
with several defective metabolic pathways that make it a poor col-
onizer of the chicken gut, but supplementation with plantain NSP
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increased colonization either through a direct nutritional source
or more likely utilization of breakdown products of microbiota
components (33). Equally immunological manipulationmay have
unexpected consequences. Both colonization of Salmonella and
Campylobacter are accompanied by regulation of innate responses
to these bacteria in the gut (13, 34, 35). It has been proposed
that depletion of the regulatory CD4+ CD25+ T-cell population
will enhance clearance and thereby reduce the public health risk
due to these pathogens (36, 37). A downside of this may be
increased inflammation and more significantly loss of regulation
to components of the microbiome, again blurring lines between
pathogen and commensal and leading to poor gut and poor health.
Conclusion
Ultimately, the “take-home” message in this article is that
the power of NGS and metagenomic approaches allow us to
understand the composition of microbiomes in multiple individ-
uals of a livestock species quickly and relatively easily. We can
associate individual taxa and species with good or poor outcomes
in productivity or health. Yet, this power needs to be tempered
with (often substantial) gaps in our understanding of microbial
ecology within the gut. Can changing the microbiota lead to
perturbation of gut regulation? As we have seen, there are blurred
lines between pathogens and commensals, and so can changes to
remove apparent pathogens have negative consequences on other
aspects of gut health or could the promotion of “good bacteria”
lead to emergence of “new pathogens.” The historical example
of growth-promoting antimicrobials illustrates the point. Their
use was successful in increasing productivity yet almost certainly
has contributed to antimicrobial resistance (38). Their subsequent
withdrawal is now resulting in problems in our faster growing
modern broiler chickens. Our understanding of the microbiome
and its manipulation offers a wealth of opportunities, though may
not be without risk.
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